Introducing RoosterVial™-hTERT-MSCs. ↪️roosterbio.com/products/roos… ✅1 million xeno-free cryopreserved cells ✅hTERT modified via non-viral plasmid gene transfer ✅>25 population doublings from working cell bank ✅>10-fold expansion in 5 days or less with RoosterNourish™

🗓️ Join our upcoming webinar! RoosterBio has established strong alignment across 3 robust, orthogonal analytical methods that allow researchers to test how process changes impact cargo content and function, an important quality attribute for MSC-EVs. ➡️us02web.zoom.us/webinar/regi…

🔍 Reduce raw material costs, time, and risk with MSC Expansion and Exosome Production Bioreactor Kits built to support scalable manufacturing, from process development through clinical manufacturing, in a variety of bioreactor platforms. Get started here➡️roosterbio.com/product-categ…

📢 Join our webinar this Thursday hosted by @BioProcessOL to learn about scalable solutions and established processes that advanced therapy programs can utilize to address key challenges associated with clinical manufacturing. Learn more & Register here➡️ event.on24.com/wcc/r/4895339…

RoosterBio has developed a xeno-free hMSC bioreactor process that preserves cell integrity and yield across different bioreactor scales and seamlessly integrates into the @PBSBiotech Vertical-Wheel® bioreactor platform for a high-performance system.➡️ roosterbio.com/resource/scal…

To maximize therapeutic potential, extracellular vesicles need established quality attributes. This webinar explores how analytical tools can assess the impact of production process choices and tissue source on the quality attributes of MSC-derived EVs. ▶️ share.hsforms.com/1tRJSy9V_T…

🗓️By utilizing scalable solutions & established processes, advanced therapy programs can meet the increased cell and exosome needs of clinical progression. Join our webinar on Cell Bank & Scale Up Strategies for MSC & Exosome Manufacturing to learn more.➡️ us02web.zoom.us/webinar/regi…

🗓️ Join our upcoming webinar, Cell Bank & Scale Up Strategies for MSC & Exosome Manufacturing, on 7/23 at 11AM (ET). This webinar will walk you through how to accelerate cell and exosome manufacturing for clinical and commercial programs. Register here➡️ us02web.zoom.us/webinar/regi…

📊 Biological components in conditioned media are a consistent problem during downstream processing of MSC-EVs. Novel AgentV™-DSP prevents filters blocking and EV loss at every step while maintaining CQAs. Download this poster to learn more: roosterbio.com/resource/scal…

🌆 RoosterBio is at the #ISSCR2025 Annual Meeting right now in Hong Kong. If you're also attending, visit us at Booth 804! Reach out to connect with Jon Rowley, Founder and CPO, and Nicholas Trotter-Mayo, Senior Director of Global Sales. roosterbio.com/contact/